Rose Loughlin, Ph.D.
As EVP of Research, Rose Loughlin, Ph.D., leads Moderna's platform science and
therapeutics research organization, focusing on pioneering scientific advancements
and further strengthening the Company’s innovative pipeline.
Dr. Loughlin previously served as Senior Vice President of Research and Early
Development at Moderna, where she played a crucial role in advancing the
Company's portfolio and platform strategy since joining in 2016. Before joining
Moderna, Dr. Loughlin held roles at Biogen in business development and at L.E.K.
Consulting, where she contributed to defining corporate and portfolio growth
strategies for biopharmaceutical companies.
Dr. Loughlin holds a Ph.D. in Biophysics from the University of California, Berkeley,
and a Bachelor of Arts in physics from Harvard University.
